Effect of low doses of atorvastatin on the urinary peptide profile of kidney transplant patients.

[1]  Harald Mischak,et al.  Urine in Clinical Proteomics* , 2008, Molecular & Cellular Proteomics.

[2]  J. Kastelein,et al.  Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[3]  R. Lauzurica,et al.  Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation? , 2007, Transplantation proceedings.

[4]  S. Baumann,et al.  Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2007, Clinical chemistry.

[5]  R. Lauzurica,et al.  Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients. , 2005, Transplantation proceedings.

[6]  D C Wheeler,et al.  Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  J. Liao,et al.  Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Wulf Palinsk.  New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering , 2001 .

[9]  W. Palinski,et al.  New evidence for beneficial effects of statins unrelated to lipid lowering. , 2001, Arteriosclerosis, thrombosis, and vascular biology.